Rep. Anna Eshoo (D-CA) (Graeme Sloan/AP Images)

Fight over where to house ARPA-H still brews with House bil­l's pas­sage

The Biden ad­min­is­tra­tion isn’t back­ing down from its de­sire to keep a new drug ac­cel­er­a­tor, known as ARPA-H, in­side the Na­tion­al In­sti­tutes of Health.

But the House on Wednes­day passed a bill by an over­whelm­ing bi­par­ti­san ma­jor­i­ty (336 to 85) to make this new ac­cel­er­a­tor a stand­alone agency.

An­na Es­hoo (D-CA), the au­thor of the House bill, made clear that the sep­a­ra­tion from NIH is in­ten­tion­al, say­ing in a state­ment that “the House passed my ARPA-H leg­is­la­tion to cre­ate a new agency with the au­thor­i­ties and au­ton­o­my it needs to be suc­cess­ful and en­sur­ing it will be a nim­ble, dy­nam­ic, and in­de­pen­dent agency.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.